is linked to TFI and C. trachomatis sero-positive women need in vitro fertilization (IVF) more often than sero-negative women. 9 In addition, positive C. trachomatis serology has been linked to lower pregnancy rates after natural conception in women with unexplained infertility 10 and non-TFI subfertility. 11 C. trachomatis may impair both tubal and endometrial function leading to lower pregnancy rates. 12 The role of C. trachomatis-induced cell-mediated immune response in unexplained infertility is less well known.
The aim of our prospective study was to evaluate the impact of past chlamydial infection on pregnancy outcomes in women with unexplained infertility by analyzing both humoral and cell-mediated immune responses against C. trachomatis.
| MATERIAL S AND ME THODS

| Study population
This study was performed in the Department of Obstetrics and Gynecology, Helsinki University Hospital, between July 2007 and December 2010. Altogether, 258 subfertile women were recruited for our previous study of C. trachomatis-induced humoral and cellmediated immunological markers in TFI diagnostics. 13 Of these 258
women, 96 (37.2%) had unexplained infertility. Those (n = 24) who conceived spontaneously before fertility workup was completed were also included in this group. The participants were followed from the first outpatient clinic visit to the first delivery or until June 2014. Women who had ectopic pregnancy before infertility evaluation or during the follow-up were considered as having TFI.
Gynecologic and obstetric history was collected from the hospital charts and background questionnaire routinely used in our clinic.
Clinical pregnancy was confirmed by ultrasound examination at 7th gestational week. Data on given fertility treatment, the following pregnancy, and delivery were collected.
| Immunological assays
Peripheral blood samples for the immunological analysis were collected at the first outpatient clinic visit. Serum IgG antibodies specific to C. trachomatis were analyzed using major outer membrane protein (MOMP) peptide-based ELISA (Medac Diagnostica, Hamburg, Germany) according to manufacturer's instruction. 13 The assay sensitivity and specificity for C. trachomatis were 99% and 65%, respectively.
Chlamydia trachomatis-specific cell-mediated immune response was studied by lymphocyte stimulation in vitro as described in our previous studies. 6, 14 Briefly, lymphocytes were stimulated by elementary body (EB) antigens of C. trachomatis serovars E and F, which represent the most prevalent serovars in Finnish population. 15 The lymphocyte proliferation (LP) responses were measured as counts per minute (cpm), and the results were expressed as mean stimulation indices (SI = mean cpm in the presence of antigen, divided by mean cpm in its absence) for triplicate cultures. SI > 5
for either E or F serovar was considered as positive response to chlamydial EB antigen. Viable cells for the LP assay were available from 89 patients. 
| Statistical analysis
| RE SULTS
| The baseline characteristics of the study population
The baseline characteristics of the study population by humoral or cell-mediated C. trachomatis-induced immune response are shown in Table 1 
| Pregnancy outcomes in women with unexplained infertility
Overall, 85 (88.5%) of the 96 women were followed over time (range 2.1-80.5 months). The given fertility therapy and the outcome of consequent pregnancy are shown in 
| D ISCUSS I ON
In our study, humoral or cell-mediated immune response against Another explanation could be persistence of C. trachomatis in the upper genital tract resulting in inflammation and impaired implantation. 16 However, we found no difference in the IVF outcome by the presence of serum antichlamydial antibodies.
Our finding of prolonged time to spontaneous pregnancy in C. trachomatis sero-positive women agrees with a larger multicenter study from the Netherlands. 10 They showed that women with unexplained infertility and serum antibodies against C. trachomatis had lower spontaneous conception rate over 12-month follow-up than sero-negative women. Steiner et al 11 also found that C. trachomatis sero-positivity decreased the probability of pregnancy and live birth among women with non-TFI infertility. However, another serologic study found no association between positive C. trachomatis antibody titers and pregnancy rates during 3-year follow-up in women with unexplained infertility, but the time of conceiving spontaneously was not studied. 17 To the best of our knowledge, this is the first study of C. trachomatis-induced cell-mediated immune response was common in our study population, but most of these women reported no history of C. trachomatis infection. Chlamydial infection is often asymptomatic and can resolve itself without treatment. 18, 19 It is also obvious that not every woman exposed to C. trachomatis develops clinical infection. Furthermore, our data of previous STIs may have suffered from recall bias, as the information was self-reported.
Immune response to C. trachomatis is complex. 20 Upon exposure to C. trachomatis, mucosal barrier of genital tract provides the first line immune defense against the pathogen and cell-mediated immune response is initiated soon after C. trachomatis enters this protective barrier. 21 The clearance of C. trachomatis is thought to depend on cell-mediated immune response which is influenced by genetic variation. 22, 23 In some women, cell-mediated immune response may induce pathological process resulting in tubal damage. 6, 21 The role of humoral immune response in controlling primary C. trachomatis infection in not clear. Antibodies may provide protective immunity against secondary infection, but the protection is short and serovar specific. 21 In our study population, the overall rate of serum antichlamydial antibodies was low. Declining trend in C. trachomatis seroprevalence rate has been observed also at the population level, while the rate of reported infections has remained high. 24, 25 It is possible that effective opportunistic screening, early diagnosis and early treatment lead to weak humoral immune response and low antibody titers after primary infection which may result in increased susceptibility to reinfection. 26 Antibody titers may also decline over time after uncomplicated C. trachomatis infection and some initially sero-positive individuals may eventually become sero-negative. 27 
| CON CLUS IONS
Based on our results, past C. trachomatis infection is unlikely to play a major role in unexplained infertility. However, time to spontaneous pregnancy in women with unexplained infertility was longer among C. trachomatis IgG sero-positive women than in sero-negative women. Positive cell-mediated immune response against C. trachomatis was common in women with unexplained infertility, but did not impact on pregnancy outcomes. Due to the increasing incidence, genital chlamydial infection still represents a major threat to fertility and more studies estimating the risk of long-term sequelae are needed. Couples with unexplained infertility usually have a good chance for spontaneous pregnancy, but better tools are needed to identify patients with poorer prognosis.
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